There have not been specific studies on using OTC nasal spray products such as Afrin in people who are pregnant or breastfeeding. However, the product labels usually include warnings for people in ...

A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) ...

Security forces of the new Syrian government’s General Security Department enter Afrin on February 6. (SANA) Forces from Syria’s General Security Department entered the northwestern Syrian city of ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

ERBIL, Kurdistan Region - Security forces affiliated with the new leadership in Damascus briefly visited Afrin on Thursday and received a warm welcome from locals, including Kurds who raised the ...

A doctor may prescribe ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if ...

ERBIL, Kurdistan Region - Four young Kurdish men were arrested in Afrin on Friday, a day after they raised the Kurdistan flag during a spontaneous reception for security forces affiliated with the ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...